Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
p-selectin glycoprotein ligand ig fusion protein (1 trial)
rpsgl-ig (2 trials)
Delayed Graft Function (Phase 2)
Ischemia (Phase 2)
Kidney Diseases (Phase 2)
Liver Diseases (Phase 2)
Reperfusion Injury (Phase 2)
Wounds and Injuries (Phase 2)
Trials (3 total)
Trial APIs (2 total)